A6842112
Pamoic acid, disodium salt , ≥98.0%(HPLC) , 6640-22-8
Synonym(s):
4,4′-Methylenebis(3-hydroxy-2-naphthoic acid);Embonic acid;Sodium pamoate
CAS NO.:6640-22-8
Empirical Formula: C23H14Na2O6
Molecular Weight: 432.33
MDL number: MFCD00036183
EINECS: 229-653-1
Pack Size | Price | Stock | Quantity |
25G | RMB176.80 | In Stock |
|
100G | RMB574.40 | In Stock |
|
250G | RMB1119.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 300 °C |
Density | 1.55[at 20℃] |
vapor pressure | 0.001Pa at 25℃ |
storage temp. | Desiccate at RT |
solubility | insoluble in EtOH; ≥18 mg/mL in H2O; ≥28.6 mg/mL in DMSO |
form | solid |
color | Pale yellow |
Water Solubility | 43g/L at 20℃ |
LogP | -3.2 at 20℃ |
CAS DataBase Reference | 6640-22-8(CAS DataBase Reference) |
EPA Substance Registry System | 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, disodium salt (6640-22-8) |
Description and Uses
Pamoic acid disodium salt, a supposedly inactive component in many formulations of drugs used to modulate release, is a potent agonist of the orphan receptor GPR35. GPR35 is a class A, rhodopsin-like G protein-coupled receptor (GPCR), strongly expressed in the lower intestine and colon, dorsal root ganglia, as well as a variety of immune cells including monocytes and dendritic cells. Targeting GPR35 provides potential therapeutic opportunities in a range of conditions, such as inflammation, pain and cancer.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H302-H315-H319-H335 |
Precautionary statements | P261-P305+P351+P338 |
Hazard Codes | Xn |
Risk Statements | 20/21/22-37/38-41-48 |
Safety Statements | 24/25-45-36/37/39-26-22 |
WGK Germany | 3 |
HS Code | 2918.29.7500 |